{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:43:13Z","timestamp":1792680193614,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["LHGJ20250537"],"award-info":[{"award-number":["LHGJ20250537"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08680-3","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:16:48Z","timestamp":1785777408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitoxyperilysis-based molecular subtyping identifies SPP1+ macrophages and IL1B as critical mediators of tumor progression and immunotherapy resistance in intrahepatic cholangiocarcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Yafei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"13","key":"8680_CR1","doi-asserted-by":"publisher","first-page":"e33931","DOI":"10.1016\/j.heliyon.2024.e33931","volume":"10","author":"G Huang","year":"2024","unstructured":"Huang G, Xi P, Yao Z, et al. The conditional recurrence-free survival after R0 hepatectomy for locally advanced intrahepatic cholangiocarcinoma: A competing risk analysis based on inflammation-nutritional status[J]. Heliyon. 2024;10(13):e33931. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33931.","journal-title":"Heliyon"},{"issue":"1","key":"8680_CR2","doi-asserted-by":"publisher","first-page":"102139","DOI":"10.1016\/j.aohep.2025.102139","volume":"31","author":"T Wu","year":"2025","unstructured":"Wu T, Du M, Zhang T, et al. Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. Ann Hepatol. 2025;31(1):102139. https:\/\/doi.org\/10.1016\/j.aohep.2025.102139.","journal-title":"Ann Hepatol"},{"issue":"1","key":"8680_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41575-025-01153-w","volume":"23","author":"JM Banales","year":"2026","unstructured":"Banales JM, Rodrigues PM, Aff\u00f2 S, et al. Cholangiocarcinoma 2026: status quo, unmet needs and priorities[J]. Nat Rev Gastroenterol Hepatol. 2026;23(1):65\u201396. https:\/\/doi.org\/10.1038\/s41575-025-01153-w.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"8680_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.20524\/aog.2025.0951","volume":"38","author":"R Medha","year":"2025","unstructured":"Medha R, Sreeram P, Daaboul O, et al. Forty-five-year trends in intra- and extrahepatic cholangiocarcinoma: sex- and race-based insights[J]. Ann Gastroenterol. 2025;38(2):214\u201320. https:\/\/doi.org\/10.20524\/aog.2025.0951.","journal-title":"Ann Gastroenterol"},{"issue":"5","key":"8680_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21037\/cco-23-144","volume":"13","author":"C Elias","year":"2024","unstructured":"Elias C, Rahman A, Mial-Anthony J, et al. Advancements in cholangiocarcinoma: evolving strategies for diagnosis, treatment, and palliation over three decades[J]. Chin Clin Oncol. 2024;13(5):70. https:\/\/doi.org\/10.21037\/cco-23-144.","journal-title":"Chin Clin Oncol"},{"key":"8680_CR6","doi-asserted-by":"publisher","first-page":"102675","DOI":"10.1016\/j.tranon.2026.102675","volume":"65","author":"X Li","year":"2026","unstructured":"Li X, Wang Y, Yin X, et al. Integrated multi-omics analysis of prognostic model and immune microenvironment in intrahepatic cholangiocarcinoma[J]. Translational Oncol. 2026;65:102675. https:\/\/doi.org\/10.1016\/j.tranon.2026.102675.","journal-title":"Translational Oncol"},{"issue":"2","key":"8680_CR7","doi-asserted-by":"publisher","first-page":"108248","DOI":"10.1016\/j.ejso.2024.108248","volume":"51","author":"AK Malik","year":"2025","unstructured":"Malik AK, Davidson BR, Manas DM. Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma[J]. Eur J Surg Oncol. 2025;51(2):108248. https:\/\/doi.org\/10.1016\/j.ejso.2024.108248.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"8680_CR8","doi-asserted-by":"publisher","first-page":"189491","DOI":"10.1016\/j.bbcan.2025.189491","volume":"1880","author":"WH Park","year":"2025","unstructured":"[8] Park WH. The mitochondrial nexus: Targeting metabolic vulnerabilities, oxidative stress, and immunomodulation to induce cancer cell death[J]. Biochim Biophys Acta Rev Cancer. 2025;1880(6):189491. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189491.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8680_CR9","doi-asserted-by":"publisher","first-page":"218077","DOI":"10.1016\/j.canlet.2025.218077","volume":"635","author":"Y Meng","year":"2025","unstructured":"Meng Y, Chen Q, Zhou Z, et al. Regulated cell death in cancer: Mechanisms, crosstalk, and opportunities for therapy[J]. Cancer Lett. 2025;635:218077. https:\/\/doi.org\/10.1016\/j.canlet.2025.218077.","journal-title":"Cancer Lett"},{"issue":"25","key":"8680_CR10","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1016\/j.cell.2025.11.002","volume":"188","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu J, Carisey AF, et al. Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis[J]. Cell. 2025;188(25):7155\u201374. https:\/\/doi.org\/10.1016\/j.cell.2025.11.002.","journal-title":"Cell"},{"key":"8680_CR11","doi-asserted-by":"crossref","unstructured":"Porro N, Sp\u00ednola-Lasso E, Marra F, et al. Immune landscape of intrahepatic cholangiocarcinoma: evasion and therapeutic insights: Immuno[Z]. 5; 2025. p. 40.","DOI":"10.3390\/immuno5030040"},{"key":"8680_CR12","doi-asserted-by":"publisher","first-page":"1697056","DOI":"10.3389\/fimmu.2025.1697056","volume":"16","author":"J Xue","year":"2025","unstructured":"Xue J, Zhang L, Zhang K, et al. Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment[J]. Front Immunol. 2025;16:1697056. https:\/\/doi.org\/10.3389\/fimmu.2025.1697056.","journal-title":"Front Immunol"},{"key":"8680_CR13","doi-asserted-by":"publisher","first-page":"967982","DOI":"10.3389\/fonc.2022.967982","volume":"12","author":"L Xu","year":"2022","unstructured":"Xu L, Yan M, Long J, et al. Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma[J]. Front Oncol. 2022;12:967982. https:\/\/doi.org\/10.3389\/fonc.2022.967982.","journal-title":"Front Oncol"},{"key":"8680_CR14","doi-asserted-by":"publisher","first-page":"115650","DOI":"10.1016\/j.intimp.2025.115650","volume":"167","author":"T Wang","year":"2025","unstructured":"Wang T, Han P, Cheng C, et al. Cholangiocarcinoma-derived SPP1 drives tumor progression by inducing macrophage chemotaxis and M2 polarization[J]. Int Immunopharmacol. 2025;167:115650. https:\/\/doi.org\/10.1016\/j.intimp.2025.115650.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"8680_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, Lu D, Chen R, et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma[J]. Cancer Cell. 2022;40(1):70\u201387. https:\/\/doi.org\/10.1016\/j.ccell.2021.12.006.","journal-title":"Cancer Cell"},{"key":"8680_CR16","doi-asserted-by":"publisher","unstructured":"Yang J, Na J, Shi T, et al. Advances in multi-omics research on biomarkers of intrahepatic cholangiocarcinoma[J]. Curr Issues Mol Biol. 2025;47(11). https:\/\/doi.org\/10.3390\/cimb47110905.","DOI":"10.3390\/cimb47110905"},{"key":"8680_CR17","doi-asserted-by":"crossref","unstructured":"Wang H, He M, Cong W et al. Immunohistochemistry in intrahepatic cholangiocarcinoma: histological subtyping and drug selection[J]. Front Oncol, 2025,Volume 15\u20132025.","DOI":"10.3389\/fonc.2025.1653534"},{"key":"8680_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.20517\/2394-5079.2024.72","volume":"10","author":"P Wei","year":"2024","unstructured":"Wei P, Li Z. Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments[J]. Hepatoma Res. 2024;10:39. https:\/\/doi.org\/10.20517\/2394-5079.2024.72.","journal-title":"Hepatoma Res"},{"issue":"12","key":"8680_CR19","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.trecan.2025.08.006","volume":"11","author":"H Li","year":"2025","unstructured":"Li H, Jin W, Liu J, et al. Optimizing mitochondria function in immune cells: implications for cancer immunotherapy[J]. Trends Cancer. 2025;11(12):1170\u201384. https:\/\/doi.org\/10.1016\/j.trecan.2025.08.006.","journal-title":"Trends Cancer"},{"key":"8680_CR20","doi-asserted-by":"publisher","unstructured":"Zhang M, Yang Y, Wu J et al. Multiple roles of mitochondria in tumorigenesis and treatment: from mechanistic insights to emerging therapeutic strategies[J]. 2025;27(3):343\u201359. https:\/\/doi.org\/10.1515\/oncologie-2024-0596","DOI":"10.1515\/oncologie-2024-0596"},{"key":"8680_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-337038","author":"J Wang","year":"2026","unstructured":"Wang J, Zhou M, Tan B, et al. SPP1(+) macrophages facilitate the differentiation and maturation of regulatory T cells in tumour-draining lymph nodes of colorectal cancer[J]. Gut. 2026. https:\/\/doi.org\/10.1136\/gutjnl-2025-337038.","journal-title":"Gut"},{"key":"8680_CR22","doi-asserted-by":"publisher","first-page":"114906","DOI":"10.1016\/j.intimp.2025.114906","volume":"160","author":"L Hou","year":"2025","unstructured":"Hou L, Jiang M, Li Y, et al. Targeting SPP1(+) macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer[J]. Int Immunopharmacol. 2025;160:114906. https:\/\/doi.org\/10.1016\/j.intimp.2025.114906.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"8680_CR23","doi-asserted-by":"publisher","first-page":"e2412740","DOI":"10.1002\/advs.202412740","volume":"12","author":"L Zuyin","year":"2025","unstructured":"Zuyin L, Zhao L, Qian C, et al. Single-Cell and Spatial Transcriptomics Delineate the Microstructure and Immune Landscape of Intrahepatic Cholangiocarcinoma in the Leading-Edge Area[J]. Adv Sci (Weinh). 2025;12(7):e2412740. https:\/\/doi.org\/10.1002\/advs.202412740.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"8680_CR24","doi-asserted-by":"publisher","first-page":"106095","DOI":"10.1016\/j.isci.2023.106095","volume":"26","author":"L Li","year":"2023","unstructured":"Li L, Zhou Y, Zhang Y, et al. A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma in vivo[J]. iScience. 2023;26(3):106095. https:\/\/doi.org\/10.1016\/j.isci.2023.106095.","journal-title":"iScience"},{"issue":"11","key":"8680_CR25","doi-asserted-by":"publisher","first-page":"e37460","DOI":"10.1097\/MD.0000000000037460","volume":"103","author":"H Ren","year":"2024","unstructured":"Ren H, Yang X, Hou W, et al. Comprehensive analysis of the clinical and biological significances for chemokine CXCL3 in cholangiocarcinoma[J]. Med (Baltim). 2024;103(11):e37460. https:\/\/doi.org\/10.1097\/MD.0000000000037460.","journal-title":"Med (Baltim)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08680-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08680-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08680-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:14:14Z","timestamp":1792678454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08680-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8680"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08680-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all participants prior to sample collection. The study protocol was reviewed and approved by the Ethics Committee of The First Affiliated Hospital of Henan University of Science and Technology and was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1333"}}